JG Chemicals Limited reported Q2 FY27 revenue of INR361.01 crores, up 64% year-on-year, EBITDA of INR38.65 crores, up 77%, and PAT of INR27.95 crores, up 86%, with a 10.71% EBITDA margin. Dahej Phase 1 trials are scheduled for next month.

3 source passages

Welcome to JG Chemicals Limited Q2 FY27 Earnings Conference Call. For Q2 FY27, our consolidated revenue from operations stood at INR361.01 crores, registering a year-on-year growth of 64% and a sequential growth of 14%. EBITDA for the quarter stood at INR38.65 crores, up 77% year-on-year and 7% sequentially with an EBITDA margin of 10.71%. Profit after tax stood at INR27.95 crores, registering a year-on-year growth of 86% and a sequential growth of 7%. Phase 1, comprising approximately 15,000 metric tons per annum of zinc oxide capacity within the planned 40,000-plus metric tons facility, is nearing completion now with trial runs scheduled for next month. Open the document at this passage

Aug 10

Earnings call

Q1 2027 earnings call AI summary on its way

May 15

Earnings call

Q4 2026 earnings call AI summary on its way

Showing 1–3 of 3 documents